Senseonics Holdings (SENS) Income from Continuing Operations (2015 - 2026)
Senseonics Holdings (SENS) posted quarterly Income from Continuing Operations of 40964000.0 for Q1 2026, down 91.26% year-over-year from 468678927.35 in Q1 2025, and down 105.69% quarter-over-quarter from 19915000.0 in Q4 2025.
Senseonics Holdings (SENS) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Income from Continuing Operations for 12 consecutive years, with 40964000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 91.26% year-over-year to 40964000.0; the TTM figure through Mar 2026 stood at 109101000.0 (down 24.22% YoY), while the FY2025 annual figure was 72036000.0, up 8.56% from the prior year.
- Income from Continuing Operations retreated to 40964000.0 in Q1 2026 per SENS's latest filing, from 19915000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 14314000.0 in Q4 2024 and bottomed at 40964000.0 in Q1 2026.
- Historically, Income from Continuing Operations has averaged 23208176.47 across 5 years, with a median of 21722000.0 in 2025.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 230.98% — and 2024, when it surged 39.92%.
- Senseonics Holdings' Income from Continuing Operations stood at 19346000.0 in 2022, then retreated by 23.14% to 23823000.0 in 2023, then soared by 39.92% to 14314000.0 in 2024, then sank by 39.13% to 19915000.0 in 2025, then slumped by 105.69% to 40964000.0 in 2026.
- Business Quant data shows SENS's Income from Continuing Operations at 40964000.0 in Q1 2026, 19915000.0 in Q4 2025, and 26500000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Senseonics Holdings | 560.79 Mn | 320.18 Mn | 8.56 Mn | -36.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -44.39 Mn |
| Mar 31, 2026 | -40.96 Mn |
| Dec 31, 2025 | -19.92 Mn |
| Sep 30, 2025 | -26.50 Mn |
| Jun 30, 2025 | -21.72 Mn |
| Mar 31, 2025 | -21.42 Mn |
| Dec 31, 2024 | -14.31 Mn |
| Sep 30, 2024 | -30.90 Mn |
| Jun 30, 2024 | -21.19 Mn |
| Mar 31, 2024 | -18.90 Mn |
| Dec 31, 2023 | -23.82 Mn |
| Sep 30, 2023 | -27.59 Mn |
| Jun 30, 2023 | -22.01 Mn |
| Mar 31, 2023 | -23.25 Mn |
| Dec 31, 2022 | -19.35 Mn |
| Sep 30, 2022 | -21.83 Mn |
| Jun 30, 2022 | -21.31 Mn |
| Mar 31, 2022 | -19.56 Mn |
| Dec 31, 2021 | -5.85 Mn |
| Sep 30, 2021 | -19.79 Mn |